| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 18, 2017First-Ever Study on 2.0 mm DES, EuroPCR Late-Breaking Data Show Exceptional Deliverability and No Stent Thrombosis for the Resolute Onyx DES
DUBLIN and PARIS- May 18, 2017 - Medtronic plc (NYSE: MDT) today announced that the Resolute Onyx(TM) Drug-Eluting Stent (DES) met its primary endpoint of Target Lesion Failure (TLF) at one year...
-
May 17, 2017Nearly 90 Percent of Patients 71 and Older Met Clinical Guidelines for Remote Monitoring
DUBLIN and CHICAGO- May 17, 2017 - A new Medtronic plc (NYSE: MDT) study shows a high use of app-based remote cardiac monitoring among older patients. Presented at Heart Rhythm 2017, the Heart...
-
May 16, 2017Late-Breaking Real-World Study Results at EuroPCR from CoreValve ADVANCE and Evolut R FORWARD Registries Show Strong Performance Consistent with Data from CoreValve Randomized Clinical Trials
DUBLIN and PARIS - May 16, 2017 - Medtronic plc (NYSE:MDT) today unveiled new positive data on the self-expanding CoreValve(TM) platform from the CoreValve ADVANCE and Evolut R FORWARD clinical...
-
May 16, 2017
DUBLIN - May 16, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 2017 Jefferies Global Healthcare Conference on Thursday, June...
-
May 15, 2017EffectivCRT(TM)and AdaptivCRT(TM) Exclusives Featured in Heart Rhythm 2017 Presentations
DUBLIN - May 15, 2017 - Medtronic plc (NYSE: MDT) today announced new data supporting the clinical performance of the company's exclusive EffectivCRT(TM) Diagnostic and AdaptivCRT(TM) algorithm in...
-
May 12, 2017Results from the REVEAL AF Study Show That AF Would Have Gone Undetected in the Majority of Patients at High-Risk for AF and Stroke If Cardiac Monitoring Was Limited to 30 Days
DUBLIN and CHICAGO - May 12, 2017 - Medtronic plc (NYSE: MDT) today announced results from a new clinical study showing Medtronic Insertable Cardiac Monitors (ICM) detected a high incidence of...
-
May 11, 2017HRS Late-Breaking Trial Reveals High Implant Success Rate and Low Early Major Complication Rate for the Medtronic Micra® Transcatheter Pacing System (TPS)
DUBLIN and CHICAGO - May 11, 2017 - Medtronic plc (NYSE: MDT) today announced preliminary results for the Medtronic Micra® Transcatheter Pacing System (TPS) Post-Approval Registry, revealing a...
-
May 10, 2017Portfolio of Next Generation Heart Failure Devices Offers Effective Pacing and Access to the Most Advanced Diagnostic Imaging Procedures
DUBLIN - May 10, 2017 - Medtronic plc (NYSE:MDT) has received U.S. Food and Drug Administration (FDA) approval for a portfolio of quadripolar cardiac resynchronization therapy-pacemakers (CRT-Ps)...
-
May 9, 2017
DUBLIN - May 9, 2017 - Medtronic plc (NYSE: MDT) announced today that it will report financial results for the fourth quarter and fiscal year 2017 on Thursday, May 25, 2017. A news release will be...
-
May 1, 2017Engineered for Exceptional Deliverability, Advanced DES Technology Features Thinner Struts, Enhanced Visibility and the Broadest Size Matrix in the U.S.
DUBLIN – May 1, 2017 – Medtronic plc (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the Resolute Onyx™ Drug-Eluting Stent (DES). The...